Bionomics Board Shakeup: New Director, Chairman Appointed
Ticker: NEUP · Form: 8-K · Filed: Oct 10, 2024 · CIK: 1191070
| Field | Detail |
|---|---|
| Company | Bionomics Limited/Fi (NEUP) |
| Form Type | 8-K |
| Filed Date | Oct 10, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, management-appointments, governance
TL;DR
Bionomics board sees a director exit, but brings in a new Chairman and Audit Committee Chair.
AI Summary
Bionomics Limited announced on October 9, 2024, the departure of Director Dr. Steven Michael, effective immediately. The company also appointed Dr. Paul R. Edick as a new Director and Chairman of the Board. Additionally, Ms. Sarah J. Grow was appointed as a Director and Chair of the Audit Committee.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board changes can introduce uncertainty regarding strategic direction and leadership stability.
Key Players & Entities
- Bionomics Limited (company) — Registrant
- Dr. Steven Michael (person) — Departing Director
- Dr. Paul R. Edick (person) — Appointed Director and Chairman of the Board
- Ms. Sarah J. Grow (person) — Appointed Director and Chair of the Audit Committee
FAQ
When did Dr. Steven Michael's departure from the board become effective?
Dr. Steven Michael's departure was effective immediately as of October 9, 2024.
Who has been appointed as the new Chairman of the Board at Bionomics Limited?
Dr. Paul R. Edick has been appointed as the new Chairman of the Board.
What is the specific role of Ms. Sarah J. Grow on the board?
Ms. Sarah J. Grow has been appointed as a Director and Chair of the Audit Committee.
What is the principal executive office address for Bionomics Limited?
The principal executive offices are located at 200 Greenhill Road, Eastwood, SA, Australia, 5063.
What is the filing date for this Current Report on Form 8-K?
The filing date for this Current Report on Form 8-K is October 10, 2024.
Filing Stats: 444 words · 2 min read · ~1 pages · Grade level 13.7 · Accepted 2024-10-10 17:00:10
Filing Documents
- ea021734401-8k_bionomics.htm (8-K) — 24KB
- 0001213900-24-086918.txt ( ) — 193KB
- bnox-20241009.xsd (EX-101.SCH) — 3KB
- bnox-20241009_lab.xml (EX-101.LAB) — 33KB
- bnox-20241009_pre.xml (EX-101.PRE) — 22KB
- ea021734401-8k_bionomics_htm.xml (XML) — 4KB
02 Departure of Directors or Certain Officers; Election of Directors;
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 9, 2024, Mr. Aaron Weaver, a member of the Board of Directors of Bionomics Limited (the "Company"), provided the Company's board with notice that he was resigning from the Board of Directors, effective October 9, 2024. Mr. Weaver's resignation does not involve any disagreement on any matter relating to the Company's operations, policies or practices. The Company thanks Mr. Weaver for his four years of service on the Company's Board of Directors, and wishes him well in all future endeavors.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIONOMICS LIMITED Date: October 10, 2024 By: /s/ Spyridon Papapetropoulos Spyridon Papapetropoulos President and Chief Executive Officer